# Section 1: Company Overview

## S1.1: Basic Information

| Field | Value |
| :---- | :---- |
| Company Name | Fevertree Drinks Plc |
| Establishment Date | 2004 |
| Headquarters Location | London, United Kingdom |


## S1.2 : Core Competencies

| Perspective | 2024 Report | 2023 Report |
| :---- | :---- | :---- |
| Innovation Advantages | The Group conducts research and development as necessary to support its principal activities, focusing innovation on broadening the product range to include cocktail mixers and adult soft drinks tailored to local drinking trends and behaviors. Innovation efforts include ingredient hunting trips and bar takeovers to build industry relationships and maintain brand authority, alongside digital transformation projects to enhance supply chain processes. | The Group conducts necessary research and development to support its principal activities, focusing on product innovation such as expanding into adjacent categories including Adult Premium Soft Drinks and Cocktail Mixers. The Technology Director leads a business transformation programme implementing cross-functional agile delivery teams to improve systems, data, and processes, enhancing operational agility and data visibility. The Group is exploring AI applications in daily routines and technology partnerships to identify further opportunities, while collaborating with supply chain partners on climate-related initiatives and innovative manufacturing practices to reduce environmental impact. |
| Product Advantages | Fever-Tree offers a broad and diversified portfolio including Tonics, Gingers, Flavoured Sodas, Cocktail Mixers, and Adult Soft Drinks, with non-Tonic products accounting for over 40% of global sales. The portfolio is designed to cater to a wide range of drinking occasions and consumer preferences, including low-calorie and non-alcoholic options, supported by strong distribution in over 90 countries and tailored product launches such as Pink Grapefruit Soda and Rosé Spritz. | Fever-Tree offers a broad and premium product portfolio, including core mixers like Tonics and Ginger Beer, as well as new ranges such as Sparkling mixers (Pink Grapefruit, Lime & Yuzu), Blood Orange Ginger Beer, and cocktail mixers like Margarita and Bloody Mary. The portfolio is designed to cater to diverse spirit occasions and consumer tastes, with strong distribution in key markets including the UK, US, and Europe. The brand leverages first mover advantage and premium pricing, maintaining significant value shares in key categories and expanding into adjacent categories to meet evolving consumer demands. |
| Brand Recognition | Fever-Tree is recognized as the best selling and top trending mixer for 11 consecutive years, maintaining a premium positioning and strong relationships with top-tier bartenders and key on-trade customers globally. The brand has a first-mover advantage in most markets, supported by strategic partnerships, extensive marketing campaigns, and collaborations such as the partnership with Molson Coors in the US and product collaborations with Mirabeau. | Fever-Tree is recognized as the number one mixer brand globally, maintaining top positions in key categories such as Tonic and Ginger Beer, and has been voted the Top Trending and Best Selling mixer brand by leading bartenders for ten consecutive years. The brand has strong relationships with customers and spirit partners, supports category growth, and operates a standalone bar in Edinburgh Airport as a platform for brand engagement. Its premium but accessible price point and focus on loyal, lifetime consumers underpin its market-leading position across global markets. |
| Reputation Ratings | Fever-Tree demonstrates a strong commitment to Environmental, Social, and Governance (ESG) principles through its Five Branches of Sustainability framework covering Climate, Circular Economy, Conservation, Communities, and Colleagues. The company has established Science Based Targets for emission reductions, manages an ESG risk register aligned with its risk governance structure, and holds certifications including Carbon Neutral Operation under PAS2060 and FSC™ and ISO 14001 for printing. It also maintains rigorous supplier standards aligned with UN and Ethical Trade Initiative codes and has received the Stakeholder Engagement Award at the 2024 Drinks Sustainability Awards. | The Group has made progress across its Five Branches of Sustainability—Climate, Circular Economy, Conservation, Communities, and Colleagues—achieving a 5% reduction in greenhouse gas emissions related to UK products in 2022 and procuring 100% renewable electricity globally. It has established a supplier risk analysis framework and human rights due diligence strategy aligned with UN ILO conventions, UNGP, and ETI Base Code. Fever-Tree launched a Diversity, Equity and Inclusion Committee with an appointed DEI Lead, received 'very good to work for' and 'top 5 food and drinks company to work for' awards, and supports long-term partnerships such as a ten-year commitment to Malaria No More UK. The Group discloses Scope 1, 2, and 3 emissions and is enhancing its decarbonisation strategy with new Sustainability KPIs from 2024. |


## S1.3 : Mission & Vision

| Field | Value |
| :---- | :---- |
| Mission Statement | To elevate the drinking experience by providing premium mixers and adult soft drinks made from the finest, naturally sourced ingredients that complement the world's best spirits, or are delicious by themselves, ensuring every sip delivers unparalleled quality and taste. |
| Vision Statement | N/A |
| Core Values | integrity, transparency, accountability |


# Section 2: Financial Performance

## S2.1: Income Statement

| Field | 2024 | 2023 | 2022 | Multiplier | Currency |
| :---- | :---- | :---- | :---- | :---- | :---- |
| Revenue | 368.5 | 364.4 | 344.3 | Millions | GBP |
| Cost of Goods Sold | (230.1) | (247.4) | (225.5) | Millions | GBP |
| Gross Profit | 138.4 | 117.0 | 118.8 | Millions | GBP |
| Operating Expense | (105.6) | (96.2) | N/A | Millions | GBP |
| Operating Income | 32.8 | 20.8 | 30.6 | Millions | GBP |
| Net Profit | 24.4 | 15.4 | 24.9 | Millions | GBP |
| Income before income taxes | 35.5 | 22.2 | 31.0 | Millions | GBP |
| Income tax expense(benefit) | (11.1) | (6.8) | (6.1) | Millions | GBP |
| Interest Expense | (0.6) | (0.6) | (0.4) | Millions | GBP |


## S2.2: Balance Sheet

| Field | 2024 | 2023 | 2022 | Multiplier | Currency |
| :---- | :---- | :---- | :---- | :---- | :---- |
| Total Assets | 321.9 | 313.7 | 311.6 | Millions | GBP |
| Current Assets | 230.7 | 225.8 | 229.1 | Millions | GBP |
| Non-Current Assets | 91.2 | 87.9 | 82.5 | Millions | GBP |
| Total Liabilities | (75.2) | (75.9) | (72.4) | Millions | GBP |
| Current Liabilities | (61.5) | (60.8) | (57.3) | Millions | GBP |
| Non-Current Liabilities | (13.7) | (15.1) | (15.1) | Millions | GBP |
| Shareholders' Equity | 246.7 | 237.8 | 239.2 | Millions | GBP |
| Retained Earnings | 191.1 | 183.1 | 184.8 | Millions | GBP |
| Total Equity and Liabilities | 321.9 | 313.7 | 311.6 | Millions | GBP |
| Inventories | 45.8 | 67.6 | 60.1 | Millions | GBP |
| Prepaid Expenses | 9.3 | 6.3 | 6.8 | Millions | GBP |


## S2.3: Cash Flow Statement

| Field | 2024 | 2023 | 2022 | Multiplier | Currency |
| :---- | :---- | :---- | :---- | :---- | :---- |
| Net Cash Flow from Operations | 70.2 | (3.8) | 8.5 | Millions | GBP |
| Net Cash Flow from Investing | (10.8) | (7.6) | (10.0) | Millions | GBP |
| Net Cash Flow from Financing | (23.6) | (23.2) | (70.7) | Millions | GBP |
| Net Increase/Decrease in Cash | 35.8 | (34.6) | (72.2) | Millions | GBP |
| Dividends | (19.6) | (19.1) | (68.8) | Millions | GBP |


## S2.4: Key Financial Metrics

| Field | 2024 | 2023 | 2022 | Multiplier | Currency |
| :---- | :---- | :---- | :---- | :---- | :---- |
| Gross Margin | 162.44% | 167.89% | 165.50% | Millions | GBP |
| Operating Margin | 8.90% | 5.71% | 8.89% | Millions | GBP |
| Net Profit Margin | 6.62% | 4.23% | 7.23% | Millions | GBP |
| Current Ratio | 375.12% | 371.38% | 399.83% | Millions | GBP |
| Quick Ratio | 285.53% | 249.84% | 283.07% | Millions | GBP |
| Interest Coverage | 5466.67% | 3466.67% | 7650.00% | Millions | GBP |
| Asset Turnover | 115.95% | 116.55% | N/A | Millions | GBP |
| Debt-to-Equity | 30.48% | 31.92% | 30.27% | Millions | GBP |
| Return on Equity | 10.07% | 6.46% | N/A | Millions | GBP |
| Return on Assets | 7.68% | 4.93% | N/A | Millions | GBP |
| Effective Tax Rate | 31.27% | 30.63% | 19.68% | Millions | GBP |
| Dividend Payout Ratio | 80.33% | 124.03% | 276.31% | Millions | GBP |

## S2.5: Operating Performance

| Field | 2024 | 2023 | 2022 |
| :---- | :---- | :---- | :---- |
| Revenue by Product/Service | N/A | N/A | N/A |
| Revenue by Geographic Region | United Kingdom: £111.1m, United States of America: £128.0m, Europe: £97.2m, Rest of the world: £32.2m | United Kingdom: £114.8m, United States of America: £117.0m, Europe: £105.4m, Rest of the world: £27.2m | United Kingdom: £116.2m, United States of America: £95.6m, Europe: £101m, Rest of the world: £31.5m |


# Section 3: Business Analysis

## S3.1: Profitability Analysis

| Field | Answer |
| :---- | :---- |
| Revenue & Direct-Cost Dynamics | Revenue growth from 2022 to 2023 was 5.1%, increasing from £344.3m to £364.4m, followed by a slight increase of 1.1% to £368.5m in 2024. Gross margin showed a slight decline from 165.50% in 2022 to 162.44% in 2024, indicating a decrease in profitability per unit sold. Revenue by geographic region in 2024 shows a shift with the United Kingdom decreasing from £116.2m in 2022 to £111.1m in 2024, while the United States increased from £95.6m in 2022 to £128.0m in 2024, highlighting a growing market presence in the U.S. Europe saw a slight increase from £101m in 2022 to £97.2m in 2024, while the Rest of the World increased from £31.5m in 2022 to £32.2m in 2024. |
| Operating Efficiency | Operating margin improved from 8.89% in 2022 to 8.90% in 2024, indicating stable operational efficiency despite fluctuations in revenue. Operating income increased from £30.6m in 2022 to £32.8m in 2024, suggesting effective cost management as operating expenses rose from £96.2m in 2023 to £105.6m in 2024. The relationship between operating income and revenue shows a positive trend, with operating income growing at a faster rate than revenue in 2024. |
| External & One-Off Impact | The effective tax rate increased significantly from 19.68% in 2022 to 31.27% in 2024, which may have impacted net profit margins, which decreased from 7.23% in 2022 to 6.62% in 2024. Non-recurring items were not specified, but the increase in tax rate could indicate changes in tax policy or profitability thresholds. External factors affecting profitability may include market conditions in the U.S. and UK, as well as potential economic shifts impacting consumer spending. |


## S3.2: Financial Performance Summary

| Perspective | 2024 Report | 2023 Report |
| :---- | :---- | :---- |
| Comprehensive financial health | In 2024, the company demonstrated a solid financial position with total assets increasing to £321.9 million from £313.7 million in 2023. The growth in non-current assets to £91.2 million indicates a focus on long-term investments. Total liabilities slightly decreased to £75.2 million, contributing to a stronger equity position of £246.7 million, up from £237.8 million in 2023. The current ratio remains robust at 375.12%, suggesting excellent liquidity and a strong capital structure. | The financial health in 2023 was stable, with total assets at £313.7 million, a slight increase from £311.6 million in 2022. Total liabilities were £75.9 million, which was manageable relative to the equity of £237.8 million. The current ratio of 371.38% indicated good liquidity, although it showed a slight decline from 399.83% in 2022, suggesting a need for careful monitoring of short-term obligations. |
| Profitability and earnings quality | In 2024, revenue grew to £368.5 million, up from £364.4 million in 2023, reflecting a positive trend in sales. Gross profit increased significantly to £138.4 million, with a gross margin of 162.44%. Operating income also improved to £32.8 million, leading to an operating margin of 8.90%. Net profit rose to £24.4 million, resulting in a net profit margin of 6.62%. Return on equity (ROE) improved to 10.07%, indicating enhanced earnings quality and sustainability. | In 2023, the company reported revenue of £364.4 million, a modest increase from £344.3 million in 2022. Gross profit was £117.0 million, with a gross margin of 167.89%, slightly lower than the previous year. Operating income was £20.8 million, yielding an operating margin of 5.71%. The net profit of £15.4 million resulted in a net profit margin of 4.23%, with ROE at 6.46%, indicating a need for improvement in profitability metrics. |
| Operational efficiency | Operational efficiency in 2024 showed significant improvement, with an operating margin of 8.90%, up from 5.71% in 2023. The company effectively managed operating expenses, which increased to £105.6 million but were offset by higher revenues. Net cash from operations surged to £70.2 million, a substantial recovery from a negative cash flow of £3.8 million in 2023, indicating better working capital management and asset utilization. | In 2023, the operating margin was 5.71%, reflecting challenges in cost management as operating expenses were £96.2 million. The negative net cash from operations of £3.8 million raised concerns about cash flow management. The asset turnover ratio remained stable at 116.55%, indicating consistent utilization of assets despite the operational challenges faced during the year. |
| Financial risk identification and early warning | In 2024, the debt to equity ratio improved to 30.48%, indicating effective debt management. The interest coverage ratio remained exceptionally high at 5466.67%, suggesting minimal financial risk from interest obligations. The effective tax rate increased slightly to 31.27%, which could impact net profitability if sustained. Overall, liquidity ratios remained strong, indicating a low risk of insolvency. | The financial risk profile in 2023 showed a debt to equity ratio of 31.92%, which was manageable but indicated a slight increase in leverage. The interest coverage ratio was also high at 3466.67%, providing a buffer against financial distress. The effective tax rate was 30.63%, which, while stable, could pose risks if tax liabilities increase. The liquidity ratios were adequate, but the current ratio's decline suggested a need for vigilance in managing short-term liabilities. |
| Future financial performance projection | Looking ahead, the company is well-positioned for growth, with strong cash flow from operations of £70.2 million supporting potential investments. The focus on maintaining a healthy dividend policy, with dividends of £19.6 million, suggests a commitment to returning value to shareholders while also investing in growth opportunities. Market expansion efforts, particularly in the United States and Europe, are likely to drive future revenue growth. | The outlook for 2023 was cautious, with net cash from operations at a negative £3.8 million, raising concerns about cash flow sustainability. The company maintained a dividend policy with £19.1 million in dividends, indicating a commitment to shareholder returns despite operational challenges. Future growth was anticipated through market expansion, particularly in the United States, but the overall performance was contingent on improving operational efficiency and profitability. |


## S3.3: Business Competitiveness

| Field | 2024 Report | 2023 Report |
| :---- | :---- | :---- |
| Business Model | Fever-Tree operates primarily on an outsourced business model, focusing on the production and distribution of premium mixers. The company generates revenue through the sale of its products, which include tonic waters, ginger beers, flavored sodas, and cocktail mixers. The brand emphasizes quality and innovation, catering to both alcoholic and non-alcoholic occasions, and has diversified its product range to include adult soft drinks. The company leverages its first-mover advantage and strong brand recognition to maintain premium pricing. | Fever-Tree operates an outsourced business model, generating revenue primarily through the sale of premium carbonated mixers and premium non-carbonated mixers. The company focuses on high-quality ingredients and has a diverse product portfolio that includes cocktail mixers and adult soft drinks. This model allows for operational flexibility and strong cash flow generation. |
| Market Position | Fever-Tree holds a leading market position in the mixer category, with a value share of 15.8% in the total mixer category and 39% in the ginger beer segment in Europe. In the US, it has a market-leading value share of 27% in tonic and 32% in ginger beer. The company is recognized as a market leader, significantly outperforming competitors, and has seen growth in both the Off-Trade and On-Trade channels. The brand's strong performance is supported by strategic partnerships, including a recent collaboration with Molson Coors, which is expected to enhance its market presence further. | Fever-Tree is the number one mixer brand globally, with a market share of over 44% in the UK mixer category and significant shares in the US Tonic and Ginger Beer categories, holding 26% and 25% respectively. The company is recognized as a market leader, leveraging its first mover advantage and strong relationships with customers and spirit partners to drive category growth and premiumisation. |


# Section 4: Risk Factors

## S4.1: Risk Factors

| Perspective | 2024 Report | 2023 Report |
| :---- | :---- | :---- |
| Market Risks | The Group faces intensified competition in the mixer category, particularly in the UK, where aggressive pricing and marketing strategies from competitors could impact market share. The Group aims to leverage its first mover advantage and invest in brand awareness to counter these challenges. | Market risk arises from the Group's interest-bearing, tradable, and foreign currency financial instruments, with fluctuations in fair value or future cash flows due to changes in interest rates and foreign exchange rates. The Group faces competition from other beverage companies, which could intensify in core markets, impacting market share and profitability. Macroeconomic volatility, including global inflation and geopolitical conflicts, heightens the risk of worsening economic conditions in key markets. |
| Operational Risks | The Group's reliance on third-party bottlers and suppliers for key ingredients poses a risk of disruption in production and supply chain continuity. To mitigate this, the Group maintains multiple suppliers and buffer stocks of essential ingredients, alongside long-term agreements to stabilize pricing. | The Group operates an asset-light, outsourced business model, which exposes it to risks related to supply chain disruptions, particularly from key ingredient suppliers. Increased competition and unanticipated actions by competitors could lead to a decline in market share or pressure on pricing. The Group's reliance on information technology systems also poses risks, as any cyber-attack could materially affect operations. |
| Financial Risks | The Group is exposed to various financial risks including credit, liquidity, pricing, and market risks. It employs derivative financial instruments like forward currency contracts to manage foreign exchange and interest rate risks, while actively monitoring its cash flow and financial obligations. | The Group is exposed to credit risk from trade receivables, with measures in place to deal only with creditworthy companies and to use credit insurance for some receivables. Liquidity risk is managed by maintaining sufficient cash holdings to cover obligations, while interest rate risk is balanced with funding costs and flexibility, although the Group does not currently engage in interest rate hedging. Foreign exchange risk is managed through forward contracts, although the policy does not fully eliminate exposure to currency fluctuations. |
| Compliance Risks | The Group is subject to significant laws and regulations, including financial reporting frameworks and health and safety legislation. Non-compliance could lead to material impacts on financial statements, prompting the Group to implement rigorous compliance reviews and audits to mitigate these risks. | The Group is subject to various laws and regulations, including health and safety legislation and employment law, where non-compliance could materially affect financial statements through fines or litigation. The Board oversees compliance through regular reviews and audits, ensuring adherence to applicable financial reporting frameworks and corporate governance codes. Increased focus on ESG-related compliance is also noted, with potential reputational risks associated with non-compliance. |


# Section 5: Corporate Governance

## S5.1: Board Composition
| Name | Position | Total Income |
| :---- | :---- | -----------: |
| Tim Warrillow | Co-Founder and Chief Executive Officer | £1,093,000 |
| Andrew Branchflower | Chief Financial Officer | £743,000 |
| Domenic De Lorenzo | Chair | £193,000 |
| Kevin Havelock | Senior Independent Non-Executive Director | £68,000 |
| Laura Hagan | Independent Non-Executive Director | £72,000 |
| Clare Swindell | Independent Non-Executive Director | £72,000 |
| David Lapp | Independent Non-Executive Director | £61,000 |

## S5.2: Internal Controls
| Perspective | 2024 Report | 2023 Report |
| :---- | :---- | :---- |
| Risk assessment procedures | The Audit Committee approved the risk strategy and reviewed the effectiveness of the risk management process, focusing on the treasury functions maturity. The Group has a risk committee in place for each functional area, which meets regularly to manage and monitor significant risks, feeding into the PLC risk register. The Audit Committee also reviewed the progress made to standardise risk management processes for identifying, evaluating, and managing principal and emerging business risks. | The Group conducts an annual climate risk deep dive, with a biannual reflection on any key changes, considering the effects that climate risks could have on its business model and long-term strategic objectives. Each risk is independently quantified against set criteria, considering both the likelihood of occurrence and the potential impact on the Group before and after the application of controls and mitigations. These assessments are recorded in the Group's Key Risk Register, which is reviewed and ratified by the Board on a bi-annual basis. |
| Control activities | The Audit Committee approved updated compliance policies for tax evasion, fraud, corruption, bribery, and whistleblowing. The Group has implemented a whistleblowing service for stakeholders to raise concerns about improprieties. The internal audit function, in collaboration with KPMG, conducted various reviews including Accounts Payable controls and a cyber security assessment. The Group also maintains a rigorous supplier quality management program and conducts regular audits and site visits to ensure compliance with standards. | The Group has a whistleblowing policy that allows employees to raise concerns about possible improprieties in financial reporting or other matters. The Audit Committee oversees the effectiveness of the Group's risk management framework and reviews the controls in place to mitigate potential adverse impacts. The Audit Committee also reviews and approves the processes for identifying, evaluating, and managing principal and emerging business risks. |
| Monitoring mechanisms | The Audit Committee receives regular reports from the Chief Financial Officer, Finance Director, and Head of Internal Audit on internal audits, control assurance work, and policy breaches. The effectiveness of the internal audit is assessed through the review of its annual audit plan and ongoing performance. The Audit Committee also monitors the effectiveness of the Group's risk management framework and oversees the internal control environment. | The Audit Committee assesses the effectiveness of Internal Audit by reviewing its annual audit plan, monitoring ongoing performance, and assessing completion rates and feedback. The Audit Committee meets regularly and has unrestricted access to the Group's Auditor. Each functional area of the Group is tasked with monitoring emerging or changing risks, and the output of these processes is subject to periodic review with the executive directors and internal Risk Committee. |
| Identified material weaknesses or deficiencies | N/A | No significant deficiencies in internal controls were reported by the external Auditor, nor reported to the Audit Committee. The Committee reports no material breaches to policy during this financial year. |
| Effectiveness | The Audit Committee is satisfied that it has carried out a robust assessment of the Group's risk management process and internal control systems. No significant deficiencies in internal controls were reported by the external auditor, and the Committee reports no material breaches to policy during the financial year. | The Audit Committee is satisfied that it has carried out a robust assessment of Fever-Tree's risk management process and internal control systems. The objective of these processes is to manage, rather than eliminate, the risk of failure to achieve business objectives, providing reasonable but not absolute assurance against material misstatement or loss. |


# Section 6: Future Outlook

## S6.1: Strategic Direction

| Perspective | 2024 Report | 2023 Report |
| :---- | :---- | :---- |
| Mergers and Acquisition | Fever-Tree announced a long-term strategic partnership with Molson Coors for exclusive sales, distribution, and production of the Fever-Tree brand in the US, effective February 1, 2025. As part of this partnership, Molson Coors acquired an 8.5% stake in Fever-Tree for £71.0 million and purchased the local trading entity Fevertree USA Inc for $23.9 million in cash. This partnership is expected to enhance Fever-Tree's market presence in the US and expand its total addressable market. | N/A |
| New technologies | Fever-Tree continues to invest in research and development to support its principal activities, focusing on innovation in product offerings. The company has launched new cocktail mixers, including Margarita, Bloody Mary, and Espresso Martini, which have gained significant traction in the US market. Additionally, the company is investing in a global operations technology program and innovation projects, with capital expenditures of £7.3 million related to these initiatives. | Fever-Tree is focused on investing in new technology to support its growth, including a global operations technology program with additions of £7.0m in intangible assets. The company is also exploring the use of AI in its operations and has established cross-functional, agile delivery teams to implement systems and processes that enhance efficiency and data visibility. |
| Organisational Restructuring | Fever-Tree is focused on talent management and workforce development, with initiatives aimed at attracting and retaining top talent. The company has launched a new intranet for learning and development, and has implemented a plan to enhance employee engagement and wellbeing. The Chief People Officer is working on succession planning and ensuring that the executive management team is appropriately compensated to encourage retention and high performance. | In 2023, Fever-Tree has made significant strides in organizational restructuring, including the establishment of a subsidiary operation in Australia and the implementation of a program to update end-to-end operational processes. The company is also focused on diversity, equity, and inclusion (DEI) initiatives, with plans to offer DEI training to all employees by 2025 and a commitment to improving employee engagement and development. |


## S6.2: Challenges and Uncertainties

| Perspective | 2024 Report | 2023 Report |
| :---- | :---- | :---- |
| Economic challenges such as inflation, recession risks, and shifting consumer behavior that could impact revenue and profitability. | The Group faces significant economic challenges due to global inflationary pressures, a cost of living crisis in the UK, and ongoing geopolitical conflicts, particularly in Ukraine and the Middle East. These factors contribute to increased input costs, reduced consumer confidence, and potential disruptions in supply chains. The heightened risk of changes in foreign policy due to numerous national elections globally may lead to new tariffs and increased local regulations, further impacting the Group's ability to maintain pricing and profitability. Additionally, the Group's exposure to downturns in consumer confidence in mature markets could affect demand for its products. | The Group faces significant economic challenges due to global inflationary pressures, ongoing geopolitical conflicts, and the impact of Brexit, which have heightened the risk of worsening economic conditions in key markets. Input cost inflation, particularly in energy and raw materials, is expected to impact margins and profitability. Additionally, reduced consumer confidence and spending could affect demand for products, making it difficult to maintain or increase prices in key markets. |
| Competitive pressures from both established industry players and new, disruptive market entrants that the company faces. | The Group is experiencing intense competitive pressures from other beverage companies in the mixer category, particularly in the UK where aggressive pricing and marketing strategies from competitors are aimed at capturing market share. The Group must navigate increased competition from both established brands and new entrants, which could lead to a decline in market share and pressure on pricing. Despite these challenges, the Group aims to leverage its first mover advantage and invest in product innovation to maintain its market position and capitalize on consumer trends towards premiumization. | The Group is experiencing intense competition from other beverage companies, particularly in the mixer category. Competitors are increasing their focus and investment in existing brands, introducing new brands, or acquiring local brands, which could pressure the Group's market share and pricing strategies. The Group's first mover advantage and strong brand reputation are critical in mitigating these competitive threats, but increased competition and unanticipated actions from rivals could adversely affect profitability and growth potential. |


## S6.3: Innovation and Development Plans

| Perspective | 2024 Report | 2023 Report |
| :---- | :---- | :---- |
| R&D investments, with a focus on advancing technology, improving products, and creating new solutions to cater to market trends | N/A | N/A |
| New product launches, emphasizing the company's commitment to continuously introducing differentiated products | In 2024, Fever-Tree launched several new products, including the Espresso Martini Mixer in the US, which gained significant traction following its launch event. Additionally, the company introduced the Rosé Spritz in collaboration with Maison Mirabeau, combining their Raspberry & Orange Blossom Soda with Mirabeau's rosé wine, tapping into the growing trend for spritz-style beverages. The Pink Grapefruit Soda also saw a strong year with a 50% sales growth, capitalizing on the popularity of premium Tequila. The company has diversified its portfolio to include cocktail mixers and adult soft drinks, which now represent a significant portion of their sales. | In 2023, Fever-Tree launched several new products, including a range of Cocktail Mixers aimed at simplifying the process of making popular cocktails at home and enhancing offerings in the On-Trade channel. Additionally, the company expanded its core mixer portfolio with the introduction of Blood Orange Ginger Beer in the US and a new range of Sparkling mixers, such as Pink Grapefruit and Lime & Yuzu, which cater to the growing popularity of long-mixed drinks. These innovations are designed to appeal to evolving consumer tastes and drinking occasions, contributing to Fever-Tree's market differentiation and growth. |
